Skip to content

Clinical trials

Phase 1/2 Papillomavirus Infections trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Papillomavirus Infections Phase: Phase 1/2 Country / region: United States Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20181
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting1
Completed1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Vaccines & Prevention B.V.1
Marengo Therapeutics, Inc.1
National Cancer Institute (NCI)1
Precigen, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Papillomavirus Infections4
Vulvar Diseases2
Vulvar Neoplasms2
Abdominal Neoplasms1
Basal Cell Carcinoma1
Biliary Tract Neoplasms1
Carcinoma1
Carcinoma in Situ1
Carcinoma, Merkel Cell1
Carcinoma, Non-Small-Cell Lung1

Trials

Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.